acetaminophen has been researched along with Anesthesia in 33 studies
Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
Anesthesia: A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.
Excerpt | Relevance | Reference |
---|---|---|
"Rectal acetaminophen (Ac) is often administered prophylactically at anesthesia induction for postoperative pain management in small children and is thought to have an opioid-sparing effect." | 9.09 | Prophylactically-administered rectal acetaminophen does not reduce postoperative opioid requirements in infants and small children undergoing elective cleft palate repair. ( Behne, M; Bremerich, DH; Heimann, K; Kessler, P; Neidhart, G, 2001) |
"Fifty-four ASA I and II children 1 to 10 yr of age undergoing strabismus surgery were randomized to receive in a double-blind fashion intravenous ketorolac (0." | 9.08 | The effects of ketorolac and fentanyl on postoperative vomiting and analgesic requirements in children undergoing strabismus surgery. ( Guarnieri, KM; Mendel, HG; Sundt, LM; Torjman, MC, 1995) |
"Acetaminophen hepatotoxicity in male CD-1 mice was enhanced markedly by brief anesthesia with diethyl ether (ether), and particularly so if acetaminophen was given several hours after ether." | 7.67 | Biochemical changes associated with the potentiation of acetaminophen hepatotoxicity by brief anesthesia with diethyl ether. ( To, EC; Wells, PG, 1986) |
"Acetaminophen does not inhibit this synthesis at the inflammatory site." | 6.55 | Pharmacology of Acetaminophen, Nonsteroidal Antiinflammatory Drugs, and Steroid Medications: Implications for Anesthesia or Unique Associated Risks. ( Candido, KD; Knezevic, NN; Perozo, OJ, 2017) |
"To investigate the effects of midazolam on emotional reactivity during induction of anesthesia in a pediatric day surgery setting." | 5.12 | High levels of impulsivity may contraindicate midazolam premedication in children. ( Buffett-Jerrott, S; Finley, GA; Millington, D; Stewart, SH; Wright, KD, 2006) |
"Peroral oxycodone is effective for early pain control after fast-track cardiac anesthesia." | 5.12 | Early oral analgesia after fast-track cardiac anesthesia. ( Eidelman, LA; Kogan, A; Medalion, B; Pak, N; Raanani, E; Sharoni, E; Stamler, A; Vidne, BA, 2007) |
"Rectal acetaminophen (Ac) is often administered prophylactically at anesthesia induction for postoperative pain management in small children and is thought to have an opioid-sparing effect." | 5.09 | Prophylactically-administered rectal acetaminophen does not reduce postoperative opioid requirements in infants and small children undergoing elective cleft palate repair. ( Behne, M; Bremerich, DH; Heimann, K; Kessler, P; Neidhart, G, 2001) |
"Fifty-four ASA I and II children 1 to 10 yr of age undergoing strabismus surgery were randomized to receive in a double-blind fashion intravenous ketorolac (0." | 5.08 | The effects of ketorolac and fentanyl on postoperative vomiting and analgesic requirements in children undergoing strabismus surgery. ( Guarnieri, KM; Mendel, HG; Sundt, LM; Torjman, MC, 1995) |
" The purposes of this study were to determine whether acetaminophen (Acet), a weak PG-synthesis inhibitor, influences kidney function in the renal PG-dependent state of anesthesia and sodium depletion." | 3.70 | Effects of acetaminophen and ibuprofen on renal function in anesthetized normal and sodium-depleted dogs. ( Colletti, AE; Rahe, T; Vogl, HW; Zambraski, EJ, 1999) |
" Additional measures included NPRS scores at predefined times over 48 hours, the summed pain intensity difference over 48 hours (SPID48), the time-weighted sum of pain relief scores over the first 8 hours, the mean dosing interval (the time from dosing to the time rescue medication or the next dose of study medication was administered, whichever was less), the proportion of patients requiring rescue medication, and the onset of perceptible and meaningful pain relief (2-stopwatch method)." | 2.74 | Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days. ( Boesing, SE; Diamond, E; Duckor, S; Gottlieb, I; Raymond, G; Riff, DS; Soulier, S, 2009) |
"Alfentanil was available via patient-controlled analgesia (PCA) during the 4-h postoperative study period." | 2.71 | Analgesic effect of i.v. paracetamol: possible ceiling effect of paracetamol in postoperative pain. ( Hahn, TW; Hjortsoe, NC; Jacobsen, LS; Lund, C; Mogensen, T; Rasmussen, M; Rasmussen, SN, 2003) |
"Acetaminophen does not inhibit this synthesis at the inflammatory site." | 2.55 | Pharmacology of Acetaminophen, Nonsteroidal Antiinflammatory Drugs, and Steroid Medications: Implications for Anesthesia or Unique Associated Risks. ( Candido, KD; Knezevic, NN; Perozo, OJ, 2017) |
"Acetaminophen was used as a surrogate for other perioperative medications in this quality improvement project." | 1.51 | Increasing compliance of safe medication administration in pediatric anesthesia by use of a standardized checklist. ( Adler, AC; Buck, D; Kanjia, MK; Varughese, AM, 2019) |
" Over 80% of total daily dosing from age 36 weeks PCA to 1 year fell within dosing suggested by pharmacokinetic studies." | 1.35 | Survey of i.v. paracetamol (acetaminophen) use in neonates and infants under 1 year of age by UK anesthetists. ( Morton, NS; Wilson-Smith, EM, 2009) |
" A close correlation between administered dosage of the drug, acetaminophen blood levels, and methemoglobinemia was found." | 1.27 | Acetaminophen-induced acute hepatic failure in pigs: controversical results to other animal models. ( Artwohl, J; Broelsch, C; Henne-Bruns, D; Kremer, B, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (21.21) | 18.7374 |
1990's | 4 (12.12) | 18.2507 |
2000's | 13 (39.39) | 29.6817 |
2010's | 8 (24.24) | 24.3611 |
2020's | 1 (3.03) | 2.80 |
Authors | Studies |
---|---|
Kleinlein, M | 1 |
Marschler, S | 1 |
Neininger, MP | 1 |
Hoeckel, M | 1 |
Bertsche, T | 1 |
Candido, KD | 1 |
Perozo, OJ | 1 |
Knezevic, NN | 1 |
Kanjia, MK | 1 |
Adler, AC | 1 |
Buck, D | 1 |
Varughese, AM | 1 |
Abdallah, FW | 1 |
Brull, R | 1 |
Joshi, GP | 1 |
Hedén, L | 1 |
von Essen, L | 1 |
Ljungman, G | 1 |
McCartney, CJ | 1 |
Nelligan, K | 1 |
Habre, W | 1 |
Veyckemans, F | 1 |
Wilson-Smith, EM | 1 |
Morton, NS | 1 |
Salonen, A | 1 |
Silvola, J | 1 |
Kokki, H | 1 |
Riff, DS | 1 |
Duckor, S | 1 |
Gottlieb, I | 1 |
Diamond, E | 1 |
Soulier, S | 1 |
Raymond, G | 1 |
Boesing, SE | 1 |
Memis, D | 1 |
Inal, MT | 1 |
Temizoz, O | 1 |
Genchallac, H | 1 |
Ozdemir, H | 1 |
Sut, N | 1 |
Danguy des Déserts, M | 1 |
Nguyen, BV | 1 |
Giacardi, C | 1 |
Commandeur, D | 1 |
Paleiron, N | 1 |
Hahn, TW | 1 |
Mogensen, T | 1 |
Lund, C | 1 |
Jacobsen, LS | 1 |
Hjortsoe, NC | 1 |
Rasmussen, SN | 1 |
Rasmussen, M | 1 |
Ahmed, MH | 1 |
Balment, RJ | 1 |
Ashton, N | 1 |
Kraft, NL | 1 |
KJAER-LARSEN, J | 1 |
KRONSCHWITZ, H | 1 |
BARTH, L | 1 |
TAYLOR, RG | 1 |
DOKU, HC | 1 |
Finley, GA | 1 |
Stewart, SH | 1 |
Buffett-Jerrott, S | 1 |
Wright, KD | 1 |
Millington, D | 1 |
Ericsson, E | 1 |
Wadsby, M | 1 |
Hultcrantz, E | 1 |
Kogan, A | 1 |
Medalion, B | 1 |
Raanani, E | 1 |
Sharoni, E | 1 |
Stamler, A | 1 |
Pak, N | 1 |
Vidne, BA | 1 |
Eidelman, LA | 1 |
Gerçek, A | 1 |
Dagcinar, A | 1 |
Ozek, MM | 1 |
Johannessen, W | 1 |
Gadeholt, G | 1 |
Aarbakke, J | 1 |
Heinze, J | 1 |
Ziese, P | 1 |
Ioannakis, K | 1 |
Mendel, HG | 1 |
Guarnieri, KM | 1 |
Sundt, LM | 1 |
Torjman, MC | 1 |
Ray, K | 1 |
Sahana, CC | 1 |
Chaudhuri, SB | 1 |
De, GC | 1 |
Chatterjee, K | 1 |
Colletti, AE | 1 |
Vogl, HW | 1 |
Rahe, T | 1 |
Zambraski, EJ | 1 |
Schmidt, A | 1 |
Björkman, S | 1 |
Akeson, J | 1 |
Bremerich, DH | 1 |
Neidhart, G | 1 |
Heimann, K | 1 |
Kessler, P | 1 |
Behne, M | 1 |
Anderson, BJ | 1 |
Meakin, GH | 1 |
Zanić-Matanić, D | 1 |
Henne-Bruns, D | 1 |
Artwohl, J | 1 |
Broelsch, C | 1 |
Kremer, B | 1 |
To, EC | 1 |
Wells, PG | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Opioid-Free Shoulder Arthroplasty[NCT03540030] | Phase 4 | 86 participants (Actual) | Interventional | 2016-09-30 | Completed | ||
Efficacy and Side Effects of Intrathecal Morphine in Multimodal Analgesia for Unilateral Total Knee Arthroplasty[NCT03232957] | 131 participants (Actual) | Interventional | 2017-08-01 | Completed | |||
Effect of Paracetamol and Ibuprofen When Intravenously Given Combination or Alone in Reducing Morphine Requirements After Total Knee Arthroplasty[NCT04414995] | Phase 2/Phase 3 | 36 participants (Actual) | Interventional | 2020-06-05 | Completed | ||
Multicenter Study to Evaluate the Analgesic Efficacy of XP21L in Subjects With Pain Following Bunionectomy Surgery[NCT00366444] | Phase 3 | 201 participants (Actual) | Interventional | 2006-08-31 | Completed | ||
Effect of Celiac Plexus Block on Gastric Emptying and Symptoms Caused by Gastroparesis[NCT02420925] | 0 participants (Actual) | Interventional | 2014-10-31 | Withdrawn (stopped due to "enrollment 0") | |||
Safety and Antipyretic Efficacy of Acetaminophen in the Febrile Intensive Care Unit Patient.[NCT02280239] | Phase 4 | 10 participants (Actual) | Interventional | 2015-05-31 | Terminated (stopped due to Only enrolled 10 participants over 9 months which is less then anticipated (75).) | ||
Comparing Pain Outcomes of Intra-operative IV Tylenol and/or IV Toradol Administration for Carpal Tunnel Release and Distal Radius Fracture Surgeries[NCT02313675] | Phase 4 | 44 participants (Actual) | Interventional | 2015-05-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
American Shoulder and Elbow Surgeons (ASES) Shoulder Score for pain and function. Range 0-100. Low score = worse shoulder condition. Function, disability, and pain subscores (all ranges 0-50), and are summed for total ASES score. (NCT03540030)
Timeframe: 2 Weeks
Intervention | units on a scale (Median) |
---|---|
Observational | 54.3 |
Non-Opioid Intervention | 54.2 |
Morphine milli-equivalents In-hospital post-operative. Continuous scale of MME, no defined better/worse. Measured as number and dose of medications taken. For example, if the patient received an opioid, the drug and dose was recorded and converted to MME. A time frame of when to assess opioid use in-hospital post-operative was not used but was a continuous monitor for rescue opioid from in-hospital post-operative through discharge. (NCT03540030)
Timeframe: In-hospital Stay
Intervention | Morphine milli-equivalents (Median) |
---|---|
Observational | 45.0 |
Non-Opioid Intervention | 19.0 |
Pain at patient discharge or 24-hours, whichever comes first - measured on a 0 (no pain) -10 (worst possible pain) numeric rating scale (NRS). A score of 0(no pain) is preferable to 10(worst possible pain) (NCT03540030)
Timeframe: 24 hours
Intervention | score on a scale (Median) |
---|---|
Observational | 3.0 |
Non-Opioid Intervention | 2.0 |
Simple Shoulder Test (SST) activity score. Range 0-12. 0 = worse activity score. (NCT03540030)
Timeframe: 2 Months
Intervention | score on a scale (Median) |
---|---|
Observational | 6 |
Non-Opioid Intervention | 6 |
Simple Shoulder Test (SST) activity score. Range 0-12. 0 = worse activity score. (NCT03540030)
Timeframe: 2 Weeks
Intervention | score on a scale (Median) |
---|---|
Observational | 2.0 |
Non-Opioid Intervention | 2.0 |
post-operative pain: measured on a 0 (no pain) -10 (worst) numeric rating scale (NRS) at 6hrs, 12hrs, 2 weeks, and 2 months. A score of 0(no pain) is preferable to 10(worst possible pain) (NCT03540030)
Timeframe: 6hrs, 12hrs, 2weeks, 2 months
Intervention | score on a scale (Median) | |||
---|---|---|---|---|
6 Hrs | 12 hrs | 2 weeks | 2 months | |
Non-Opioid Intervention | 0.0 | 0 | 0.82 | 0 |
Observational | 2 | 4 | 1.3 | 0.7 |
rate of constipation (NCT03540030)
Timeframe: 2 Months
Intervention | Participants (Count of Participants) | ||
---|---|---|---|
Yes | No | Unknown | |
Non-Opioid Intervention | 4 | 27 | 4 |
Observational | 7 | 21 | 2 |
rate of constipation (NCT03540030)
Timeframe: 2 Weeks
Intervention | Participants (Count of Participants) | ||
---|---|---|---|
Yes | No | Unknown | |
Non-Opioid Intervention | 13 | 22 | 0 |
Observational | 19 | 9 | 2 |
rate of falls (NCT03540030)
Timeframe: 2 Months
Intervention | Participants (Count of Participants) | ||
---|---|---|---|
Yes | No | Unknown | |
Non-Opioid Intervention | 4 | 27 | 4 |
Observational | 4 | 24 | 2 |
rate of falls (NCT03540030)
Timeframe: 2 Weeks
Intervention | Participants (Count of Participants) | ||
---|---|---|---|
Yes | No | Unknown | |
Non-Opioid Intervention | 5 | 30 | 0 |
Observational | 1 | 27 | 2 |
rate of nausea (NCT03540030)
Timeframe: 2 Months
Intervention | Participants (Count of Participants) | ||
---|---|---|---|
Yes | No | Unknown | |
Non-Opioid Intervention | 1 | 30 | 0 |
Observational | 0 | 28 | 2 |
rate of nausea (NCT03540030)
Timeframe: 2 Weeks
Intervention | Participants (Count of Participants) | ||
---|---|---|---|
Yes | No | Unknown | |
Non-Opioid Intervention | 1 | 34 | 0 |
Observational | 5 | 23 | 2 |
Satisfaction with overall pain using Numeric Pain Rating (NRS) scale. yes, no. No being better than yes. (NCT03540030)
Timeframe: 2 Months
Intervention | Participants (Count of Participants) | ||
---|---|---|---|
Yes | No | Unknown | |
Non-Opioid Intervention | 29 | 2 | 4 |
Observational | 23 | 5 | 2 |
Satisfaction with overall pain using Numeric Pain Rating (NRS) scale. yes, no. No being better than yes. (NCT03540030)
Timeframe: 2 Weeks
Intervention | Participants (Count of Participants) | ||
---|---|---|---|
Yes | No | Unknown | |
Non-Opioid Intervention | 34 | 1 | 0 |
Observational | 27 | 1 | 2 |
quality of life using VR-12 subscores. Physical Health (PCS) subscore and Mental Health (MCS) subscore, not summed. Range reported in weighted units. Physical Health subscore: 1 point increase in PCS is associated with 6% lower total health care expenditures, 5% lower pharmacy expenditures, 9% lower rate of hospital inpatient visits, 4% lower rate of medical provider visits, 5% lower rate of hospital outpatient visits. Mental Health sub score a 1 point increase in MCS is associated with 7% lower total health care expenditures, 4% lower pharmacy expenditures, 15% lower rate of hospital inpatient visits, and 4% lower rate of medical provider visits. Both PCS/MCS are score 0-100 with 100 indicating the highest level of health. (NCT03540030)
Timeframe: 2 Months
Intervention | score on a scale (Median) | |
---|---|---|
PCS | MCS | |
Non-Opioid Intervention | 40.3 | 60.8 |
Observational | 38.4 | 58.7 |
quality of life using VR-12 subscores. Physical Health (PCS) subscore and Mental Health (MCS) subscore, not summed. Range reported in weighted units. Physical Health subscore: 1 point increase in PCS is associated with 6% lower total health care expenditures, 5% lower pharmacy expenditures, 9% lower rate of hospital inpatient visits, 4% lower rate of medical provider visits, 5% lower rate of hospital outpatient visits. Mental Health sub score a 1 point increase in MCS is associated with 7% lower total health care expenditures, 4% lower pharmacy expenditures, 15% lower rate of hospital inpatient visits, and 4% lower rate of medical provider visits. Both PCS/MCS are score 0-100 with 100 indicating the highest level of health. (NCT03540030)
Timeframe: 2 Weeks
Intervention | score on a scale (Median) | |
---|---|---|
PCS | MCS | |
Non-Opioid Intervention | 35.0 | 59.1 |
Observational | 36.7 | 56.3 |
Pain intensity scores were measured using an 11-point numerical pain rating scale (NPRS) with 0=no pain to 10=worst possible pain (NCT00366444)
Timeframe: Over 48 hours after bunionectomy
Intervention | units on a scale (Mean) |
---|---|
Zipsor (Diclofenac Potassium) Liquid Filled Capsule | 2.5 |
Placebo | 5.6 |
(NCT00366444)
Timeframe: 8 hours post single dose
Intervention | minutes (Median) |
---|---|
Zipsor (Diclofenac Potassium) Liquid Filled Capsule | 70.2 |
(NCT00366444)
Timeframe: 8 hours post single dose
Intervention | minutes (Median) |
---|---|
Zipsor (Diclofenac Potassium) Liquid Filled Capsule | 26.0 |
Placebo | 22.2 |
(NCT00366444)
Timeframe: Day 1
Intervention | participants (Number) |
---|---|
Zipsor (Diclofenac Potassium) Liquid Filled Capsule | 40 |
Placebo | 87 |
(NCT00366444)
Timeframe: Day 2
Intervention | participants (Number) |
---|---|
Zipsor (Diclofenac Potassium) Liquid Filled Capsule | 22 |
Placebo | 64 |
Day 3 data reflect the use of rescue medication only up to the time of discharge (NCT00366444)
Timeframe: Day 3
Intervention | participants (Number) |
---|---|
Zipsor (Diclofenac Potassium) Liquid Filled Capsule | 5 |
Placebo | 29 |
(NCT00366444)
Timeframe: 8 hours post single dose
Intervention | participants (Number) |
---|---|
Zipsor (Diclofenac Potassium) Liquid Filled Capsule | 62 |
Placebo | 40 |
Times to onset of Perceptible and Meaningful Relief were determined using the double-stopwatch method. (NCT00366444)
Timeframe: 8 hours post single dose
Intervention | participants (Number) |
---|---|
Zipsor (Diclofenac Potassium) Liquid Filled Capsule | 58 |
Placebo | 35 |
Times to onset of Perceptible and Meaningful Relief were determined using the double-stopwatch method. (NCT00366444)
Timeframe: 8 hours post single dose
Intervention | participants (Number) |
---|---|
Zipsor (Diclofenac Potassium) Liquid Filled Capsule | 84 |
Placebo | 69 |
(NCT00366444)
Timeframe: 8 hours post single dose
Intervention | minutes (Median) |
---|---|
Zipsor (Diclofenac Potassium) Liquid Filled Capsule | 60 |
Pain relief was rated using a 5-point categorial scale (0=none, 1=a little, 2=some, 3=a lot, and 4=complete) at time of dose (time=0) and over 15 time points afterwards (10, 15, 20, 30, 45, and 60 minutes and at 1.5, 2, 2.5, 3, 4, 5, 6, 7, and 8 hours after the initial dose on Day 1 or until time of re-medication). A score of 0 across all time points would be the lowest (worst) and a score of 60 (4 X 15 time points) would be the highest (best) possible score. (NCT00366444)
Timeframe: 8 hours post single dose
Intervention | units on a scale (Mean) |
---|---|
Zipsor (Diclofenac Potassium) Liquid Filled Capsule | 8.2 |
Placebo | 2.6 |
Clinically significant hypotension is defined as an acute drop in mean arterial pressure requiring treatment. Treatment is defined as either a 500 cc (or greater) fluid bolus and/or an increase in inotrope support of greater than 5 mcg/min over baseline. (NCT02280239)
Timeframe: 4 hours post acetaminophen administration
Intervention | Participants (Count of Participants) |
---|---|
Control Group | 0 |
Acetaminophen Group | 0 |
systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressures (MAP) will be monitored for 4 hours post intervention (NCT02280239)
Timeframe: 4 hours post intervention
Intervention | mmHg (Mean) | |||||
---|---|---|---|---|---|---|
SBP: Pre-Intervention (2 hours) | SBP: Post-Intervention (4 hours) | DBP: Pre-Intervention (2 hours) | DBP: Post-Intervention (4 hours) | MAP: Pre-Intervention (2 hours) | MAP: Post-Intervention (4 hours) | |
Acetaminophen Group | 122.6 | 119.5 | 66.2 | 65.4 | 84.1 | 82.4 |
Control Group | 141.6 | 141.5 | 57.4 | 51.0 | 80.8 | 75.5 |
"Total dose of all vasoactive medications will be converted to total Equidose value (with the formula 10 mcg/min norepinephrine ≈ 5 mcg/kg/min dopamine ≈ 10 mcg/min epinephrine ≈ 1 mcg/min phenylephrine ≈ 0.02 u/min vasopressin as per Russell et al. (2008)) before comparing the treatment and control groups~Only 2 of the 6 participants were on low-dose vasoactive medications, (i.e., one was on norepinephrine and the other was on milrinone) therefore the pre-planned conversion calculation was not done." (NCT02280239)
Timeframe: 4 hours post intervention
Intervention | mcg (Number) | |||
---|---|---|---|---|
Pre-Intervention (2 hours) TOTAL Norepinephrine | Pre-Intervention (2 hours) TOTAL Milrinone | Post-Intervention (4 hours) TOTAL Norepinephrine | Post-Intervention (4 hours) TOTAL Milrinone | |
Acetaminophen Group | NA | 6000.0 | NA | 7000.0 |
Control Group | 167.0 | NA | 576.0 | NA |
Total crystalloid and colloid fluid will be converted the the equi-volume dose (with the ratio 1.4:1 (as per Finfer et al.(2004) & Vincent and Weil (2006) before making comparisons between the treatment and control groups. (NCT02280239)
Timeframe: 4 hours post intervention
Intervention | mL (Mean) | |||
---|---|---|---|---|
Pre-Intervention (2 hours) Total fluid INTAKE | Pre-Intervention (2 hours) Total fluid OUTPUT | Post-Intervention (4 hours) Total Fluid INTAKE | Post-Intervention (4 hours) Total Fluid OUTPUT | |
Acetaminophen Group | 298 | 370 | 612 | 852 |
Control Group | 235 | 80 | 734 | 245 |
"Continuous measurements of core body temperature will be recorded for 6 hours. Fever burden (FB) is defined as area between the 6 hour temperature curve and 38.3°C cut-off and it is reported in °C-hour.~PRE-INTERVENTION FB: is reported for a 2 hour period. POST-INTERVENTION FB: post-intervention fever burden is reported for a 6 hour period and average hourly fever burden.~Peak Temperature: is the highest recorded temperature for the study period in °C Minimum Temperature: is the lowest recorded temperature for the study period in °C" (NCT02280239)
Timeframe: 6 hours post intervention
Intervention | °C*hours (Mean) | |
---|---|---|
Pre-Intervention FB (2 hours) | Post-Intervention FB (6 hours) | |
Acetaminophen Group | 2.16 | 5.65 |
Control Group | 0.97 | 0.74 |
"Daily opioid consumption assessed as number of pills taken that day, each day for 7 days post-operatively~Outcome measure reported below is mean number of opioid pills consumed per day." (NCT02313675)
Timeframe: 7 days
Intervention | pills consumed (Mean) |
---|---|
IV Tylenol | 0.2 |
IV Toradol | 0.7 |
IV Tylenol/Toradol Combination | 1.0 |
Saline | 0.7 |
This is an ordinal pain scale. The patient picks a number from 0-10 scale every 4 hours for 7 days post-operatively. 0 is no pain, 10 is the worst pain imaginable. Lower scores would be preferable to higher scores. (NCT02313675)
Timeframe: 7 days
Intervention | units on a scale (Mean) |
---|---|
IV Tylenol | 2.0 |
IV Toradol | 2.9 |
IV Tylenol/Toradol Combination | 2.7 |
Saline | 2.0 |
5 reviews available for acetaminophen and Anesthesia
Article | Year |
---|---|
Pharmacology of Acetaminophen, Nonsteroidal Antiinflammatory Drugs, and Steroid Medications: Implications for Anesthesia or Unique Associated Risks.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthesia; Anti-Inflammatory Agents, N | 2017 |
Pain Management for Ambulatory Arthroscopic Anterior Cruciate Ligament Reconstruction: Evidence-Based Recommendations From the Society for Ambulatory Anesthesia.
Topics: Acetaminophen; Ambulatory Care; Ambulatory Surgical Procedures; Analgesics; Anesthesia; Anesthesia, | 2019 |
Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.
Topics: Acetaminophen; Acute Pain; Aged; Analgesics, Opioid; Anesthesia; Anesthesia, Conduction; Anti-Inflam | 2014 |
Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.
Topics: Acetaminophen; Acute Pain; Aged; Analgesics, Opioid; Anesthesia; Anesthesia, Conduction; Anti-Inflam | 2014 |
Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.
Topics: Acetaminophen; Acute Pain; Aged; Analgesics, Opioid; Anesthesia; Anesthesia, Conduction; Anti-Inflam | 2014 |
Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.
Topics: Acetaminophen; Acute Pain; Aged; Analgesics, Opioid; Anesthesia; Anesthesia, Conduction; Anti-Inflam | 2014 |
Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.
Topics: Acetaminophen; Acute Pain; Aged; Analgesics, Opioid; Anesthesia; Anesthesia, Conduction; Anti-Inflam | 2014 |
Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.
Topics: Acetaminophen; Acute Pain; Aged; Analgesics, Opioid; Anesthesia; Anesthesia, Conduction; Anti-Inflam | 2014 |
Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.
Topics: Acetaminophen; Acute Pain; Aged; Analgesics, Opioid; Anesthesia; Anesthesia, Conduction; Anti-Inflam | 2014 |
Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.
Topics: Acetaminophen; Acute Pain; Aged; Analgesics, Opioid; Anesthesia; Anesthesia, Conduction; Anti-Inflam | 2014 |
Postoperative pain management after total knee arthroplasty in elderly patients: treatment options.
Topics: Acetaminophen; Acute Pain; Aged; Analgesics, Opioid; Anesthesia; Anesthesia, Conduction; Anti-Inflam | 2014 |
A pictorial and video guide to circumcision without pain.
Topics: Acetaminophen; Analgesia; Analgesics, Non-Narcotic; Anesthesia; Anesthetics, Local; Attitude of Heal | 2003 |
Scaling for size: some implications for paediatric anaesthesia dosing.
Topics: Acetaminophen; Adolescent; Adult; Analgesics, Opioid; Anesthesia; Anesthetics; Body Constitution; Bo | 2002 |
14 trials available for acetaminophen and Anesthesia
Article | Year |
---|---|
Effect of high-dose paracetamol on needle procedures in children with cancer--an RCT.
Topics: Acetaminophen; Acute Pain; Adolescent; Analgesics, Non-Narcotic; Anesthesia; Child; Child, Preschool | 2014 |
Does 1 or 2 g paracetamol added to ketoprofen enhance analgesia in adult tonsillectomy patients?
Topics: Acetaminophen; Adolescent; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthesia; Anti-Inf | 2009 |
Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days.
Topics: Acetaminophen; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthesia; An | 2009 |
The effect of celiac plexus block in critically ill patients intolerant of enteral nutrition: a randomized, placebo-controlled study.
Topics: Acetaminophen; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Anesthesia; APACHE; Blood Glucose; | 2010 |
Analgesic effect of i.v. paracetamol: possible ceiling effect of paracetamol in postoperative pain.
Topics: Absorption; Acetaminophen; Adult; Alfentanil; Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthes | 2003 |
High levels of impulsivity may contraindicate midazolam premedication in children.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Analysis of Variance; Anesthesia; Anesthetics, Intravenous; | 2006 |
Pre-surgical child behavior ratings and pain management after two different techniques of tonsil surgery.
Topics: Acetaminophen; Adolescent; Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthesia; Anti-Inflammato | 2006 |
Early oral analgesia after fast-track cardiac anesthesia.
Topics: Acetaminophen; Administration, Oral; Aged; Analgesia; Analgesics, Opioid; Anesthesia; Anti-Inflammat | 2007 |
[Strabismus surgery in children. The effect of paracetamol and bupivacaine].
Topics: Acetaminophen; Anesthesia; Arousal; Bupivacaine; Child, Preschool; Female; Humans; Male; Pain Measur | 1995 |
The effects of ketorolac and fentanyl on postoperative vomiting and analgesic requirements in children undergoing strabismus surgery.
Topics: Acetaminophen; Ambulatory Surgical Procedures; Analgesics, Non-Narcotic; Anesthesia; Child; Child, P | 1995 |
Effects of trichloroethylene anaesthesia on salivary paracetamol elimination.
Topics: Acetaminophen; Adult; Anesthesia; Anesthesia, General; Half-Life; Humans; Male; Salivary Glands; Tri | 1993 |
Preoperative rectal diclofenac versus paracetamol for tonsillectomy: effects on pain and blood loss.
Topics: Acetaminophen; Administration, Rectal; Adult; Analgesics, Non-Narcotic; Anesthesia; Anti-Inflammator | 2001 |
Prophylactically-administered rectal acetaminophen does not reduce postoperative opioid requirements in infants and small children undergoing elective cleft palate repair.
Topics: Acetaminophen; Administration, Rectal; Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthesia; Cle | 2001 |
[Clinical evaluation of analgesics in surgical patients in the postoperative period].
Topics: Acetaminophen; Adult; Aged; Anesthesia; Clinical Trials as Topic; Dextropropoxyphene; Double-Blind M | 1987 |
14 other studies available for acetaminophen and Anesthesia
Article | Year |
---|---|
Y-site administration of electrolyte solutions and injectable acetaminophen-A physical compatibility study with combinations frequently used in pediatric intensive care and anesthesia.
Topics: Acetaminophen; Anesthesia; Child; Critical Care; Humans | 2023 |
Increasing compliance of safe medication administration in pediatric anesthesia by use of a standardized checklist.
Topics: Acetaminophen; Anesthesia; Checklist; Child; Electronic Health Records; Hospitals, Pediatric; Humans | 2019 |
Do not add to the stress: is paracetamol prescription well tolerated by children?
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anesthesia; Asthma; Child; Humans | 2014 |
Survey of i.v. paracetamol (acetaminophen) use in neonates and infants under 1 year of age by UK anesthetists.
Topics: Acetaminophen; Age Factors; Analgesics, Non-Narcotic; Anesthesia; Drug Utilization; Female; Health C | 2009 |
[Acetaminophen-induced hypotension after intravenous and oral administration].
Topics: Acetaminophen; Administration, Oral; Aged; Analgesics, Non-Narcotic; Anesthesia; Critical Care; Huma | 2010 |
Renal action of acute chloroquine and paracetamol administration in the anesthetized, fluid-balanced rat.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anesthesia; Animals; Chloroquine; Glomerular Filtration Rat | 2003 |
[Napatyl, a new analgesic; clinical evaluation of N-acetyl-p-aminophenol with codeine].
Topics: Acetaminophen; Acetanilides; Analgesia; Analgesics; Anesthesia; Anesthesia and Analgesia; Codeine; P | 1956 |
[The new nitrous oxide anesthesia apparatus Medi LN 418; evaluation and description].
Topics: Acetaminophen; Anesthesia; Anesthesiology; Humans; Nitrous Oxide | 1957 |
USE OF A 'SOMA' COMPOUND IN PAIN CONTROL AFTER ORAL SURGERY.
Topics: Acetaminophen; Amphetamine; Analgesics; Analgesics, Non-Narcotic; Anesthesia; Anesthesia, Dental; An | 1963 |
Anesthetic management of a newborn with Mohr (oro-facial-digital type II) syndrome.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anesthesia; Anesthetics, Inhalation; Anesthetics, Intraveno | 2007 |
Effects of diethyl ether anaesthesia on the pharmacokinetics of antipyrine and paracetamol in the rat.
Topics: Acetaminophen; Anesthesia; Animals; Antipyrine; Ether; Ethyl Ethers; Kinetics; Male; Metabolic Clear | 1981 |
Effects of acetaminophen and ibuprofen on renal function in anesthetized normal and sodium-depleted dogs.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anesthesia; Animals; Anti-Inflammatory Agents, Non-Steroida | 1999 |
Acetaminophen-induced acute hepatic failure in pigs: controversical results to other animal models.
Topics: Acetaminophen; Acute Disease; Anesthesia; Animals; Chemical and Drug Induced Liver Injury; Disease M | 1988 |
Biochemical changes associated with the potentiation of acetaminophen hepatotoxicity by brief anesthesia with diethyl ether.
Topics: Acetaminophen; Alanine Transaminase; Anesthesia; Animals; Drug Synergism; Ether; Ethyl Ethers; Glucu | 1986 |